rasagiline 1mg tablets
caduceus pharma ltd - rasagiline - tablets - 1mg - anti-parkinson-drugs, monoamine oxidase -b inhibitors - it is indicated for the treatment of idiopathic parkinson’s disease (pd) as monotherapy (without levodopa) or as adjunct therapy (with levodopa) in patients with end of dose fluctuations.
rasagiline - trima
trima israel pharmaceutical products maabarot ltd - rasagiline as mesylate - tablets - rasagiline as mesylate 1 mg - rasagiline - treatment of idiopathic parkinson's disease (pd) as monotherapy (without levodopa) or as adjunct therapy (with levodopa) in patients with end of dose fluctuations.
rasagiline 1mg tablets
a a h pharmaceuticals ltd - rasagiline - tablet - 1mg
rasagiline 1mg tablets
hbs healthcare ltd - rasagiline - tablet - 1mg
rasagiline 1mg tablets
dr reddy's laboratories (uk - rasagiline - tablet - 1mg
rasagiline 1mg tablets
accord healthcare ltd - rasagiline - tablet - 1mg
rasagiline 1mg tablets
rivopharm (uk - rasagiline - tablet - 1mg
rasagiline 1mg tablets
milpharm ltd - rasagiline - tablet - 1mg
azilect
teva israel ltd - rasagiline as mesylate - tablets - rasagiline as mesylate 1 mg - rasagiline - rasagiline - azilect is indicated for the treatment of idiopathic parkinson's disease (pd) as monotherapy (without levodopa)or as adjunct therapy (with levodopa) in patients with end of dose fluctuations.
azilect
teva pharmaceutical industries ltd, israel - rasagiline as mesylate - tablets - rasagiline as mesylate 1 mg - rasagiline - rasagiline - azilect is indicated for the treatment of idiopathic parkinson's disease (pd) as monotherapy (without levodopa)or as adjunct therapy (with levodopa) in patients with end of dose fluctuations.